GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Perfis / Ana Paula Arez
Ana Paula Arez
  • +351 213 652 600
  • +351 213 632 105
  • Enviar Mail
  • Download CV
  • Orcid
  • NOVA Research

Ana Paula Arez

Principal Researcher

Cross-cutting Issue Facilitator Diagnostics

Grupo GHTM: VBD PhD members, Vector-borne diseases and pathogens

ProfileResearchTop 5 Publications

Ana Paula Arez is Principal Investigator (with Habilitation) at the Medical Parasitology Unit of Institute of Hygiene and Tropical Medicine (IHMT) and at Global Health and Tropical Medicine Center (GHTM) of Universidade NOVA de Lisboa (UNL). She holds a PhD in Biology (2000) and a BSc in Biology (1992) by the Faculty of Sciences, University of Lisbon.

She teaches at Biomedical Sciences, Parasitology and Global Health PhD and MSc courses of IHMT NOVA and supervises and/or co-supervises Post-docs, PhD and MSc students. She conducts expert review of scientific papers and projects in national and international journal and funding agencies on regular basis.

Presently at IHMT, she is vice-President of the Institute Council, member of the Scientific Council, Facilitator of the GHTM’s Cross Cutting Issue Diagnostics and General Coordinator of the GHTM biobank – Biotropical Resources.

Ana Paula Martins dos Reis Arez CIÊNCIAVITAE’s CV

 

Main lines of research: 1) Human host and parasite interactions (human factors of susceptibility and resistance against malaria), 2) Molecular epidemiology of malaria, and 3) Development of new diagnostic methods.

Her first interest has been malaria epidemiology, transmission dynamics, interactions and ecological relationships between different parasites co-infecting the same host and several research projects in malaria endemic areas, namely Guinea-Bissau, Cape Verde, Mozambique, and Equatorial Guinea were conducted. During the studies in Cape Verde (doi:10.1017/s0031182099003972, doi:10.1186/1475-2875-5-32), the observation that infected people developed mild symptoms in spite of their presumptive weak immune status and high parasitaemia aroused interest on the human factors of susceptibility to malaria. Some protective human variants are those involving the erythrocyte-specific structural proteins and enzymes so research on the association of enzyme disorders on the RBC glycolytic and pentose-phosphate pathways and protection against the Plasmodium parasite has been initiated. Population studies showed that malaria infection was the most likely selective pressure that seems to shape both the pklr and tpi genomic regions in individuals from malaria endemic countries (doi:10.1016/j.bcmd.2009.09.008, doi:10.1111/j.1365-2141.2010.08165.x, doi:10.1371/journal.pone.0047071, doi:10.1016/j.meegid.2015.03.020).

Looking then at biological processes involved, we hypothesised that the accumulation of 2,3-DPG due to a deficiency in pyruvate kinase could create an unsuitable environment for parasite and could be involved in the protection mechanism. Results showed an inhibition of parasite growth as significantly lower progeny from parasites subjected to treatment; no effect was observed on the host cell, instead, the metabolic profile of 2,3-DPG treated infected cells became closer to that of non-infected cells (doi:10.3389/fcimb.2022.840968, Carvalho et al. submitted).

Additionally, being aware that prompt and accurate diagnosis is essential to prevent a mild malaria case from developing into severe disease or death, she has been involved in studies to develop new simple, rapid and sensitive molecular diagnostic tests to characterise malaria infected isolates.

  1. Morais, I., Medeiros, M.M., Carvalho, M., Morello, J., Teixeira, S.M., Maciel, S., Nhantumbo, J., Balau, A., Rosa, M.T.G., Nogueira, F., Rodrigues, J.A., Carvalho, F.A., Antunes, A.M.M., Arez, A.P. (2022). Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro. Frontiers in Cellular and Infection Microbiology, 12, 840968. doi: 10.3389/fcimb.2022.840968.
  2. Guerra, M., Neres, R., Salgueiro, P., Mendes, C., Ndong-Mabale, N., Berzosa, P., de Sousa, B., Arez, A.P. (2017). Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy. Antimicrobial Agents and Chemotherapy, 61: e02556-15. doi: 10.1128/AAC.02556-15.
  3. Machado, P., Manco, L., Gomes, C., Mendes, C., Fernandes, N., Salomé, G., Sitoe, L., Chibute, S., Langa, J., Ribeiro, L., Miranda, J., Cano, J., Pinto, J., Amorim, A., do Rosário, V.E., Arez, A.P. (2012). Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria. PLoS ONE, 7: e47071. doi: 10.1371/journal.pone.0047071.
  4. Mendes, C., Dias, F., Figueiredo, J., Gonzalez, V.M., Cano, J., de Sousa, B., do Rosário, V.E., Benito, A., Berzosa, P., Arez, A.P. (2011). Duffy negative antigen is no longer a barrier to Plasmodium vivax – molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Neglected Tropical Diseases, 5: e1192. doi: 10.1371/journal.pntd.0001192.
  5. Machado, P., Pereira, R., Rocha, A.M., Manco, L., Fernandes, N., Miranda, J., Ribeiro, L., do Rosário, V.E., Amorim, A., Gusmão, L., Arez, A.P. (2010). Malaria: looking for selection signatures in the human PKLR gene region. British Journal of Haematology, 149: 775-784. doi:10.1111/j.1365-2141.2010.08165.x.

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013